4 ms·
Yeah, right now the cost of the drug itself is high, but as that comes down and/or once the patents expire, it's a no brainer for insurance companies to fund it
by crooked-v 2y ago
Yeah, right now the cost of the drug itself is high, but as that comes down and/or once the patents expire, it's a no brainer for insurance companies to fund it, in the same way that even the worst health insurance plans usually allow for cheap office visits and free flu vaccinations.
- subroutine 2y agoI agree if the cost becomes negligible or whenever it becomes cost effective (I'm sure the insurance companies will be tracking the data closely) - until then though?